Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Oct 14 (Reuters) — Oncolytics Biotech Inc: Oncolytics Biotech® Provides Update On Goblet Study Clinical Data And Final Pancan Grant Payment Oncolytics Biotech - Final Cohort 4 Results Expected In Q4 2026; Initial Cohort 5 Results In H1 2027 Oncolytics Biotech - To Receive Final Pancan Grant Payment Later This Quarter S
Oncolytics Biotech expects final GOBLET Cohort 4 results in fourth-quarter 2026; initial Cohort 5 results are expected in first-half 2027. Cohort 4 tests pelareorep with atezolizumab in anal cancer; Cohort 5 evaluates pelareorep-based combinations in previously untreated metastatic pancreatic cancer. Every fully enroll